Catalyst
Slingshot members are tracking this event:
Kite Pharma Licenses Enabling Technology for the Development of Off-the-Shelf Allogeneic T-Cell Therapies
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KITE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 25, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Allogenic T-cell Therapies, Ato System, Renewable Pluripotent Stem Cells
